EDNRA and systemic sclerosis: In the last decade, a growing body of evidence has highlighted that several G protein-coupled receptors (GPCR) are targeted in SSc by functional autoantibodies, whose altered levels, cross-reactivity, and synergistic effects may influence the disease pathogenesis [4,84].